Skip to main navigation Skip to search Skip to main content

Does supplementation with leucine-enriched protein alone and in combination with fish-oil-derived n-3 PUFA affect muscle mass, strength, physical performance, and muscle protein synthesis in well-nourished older adults? A randomized, double-blind, placebo-controlled trial

  • C.H. Murphy
  • , E.M. Flanagan
  • , G. De Vito
  • , D. Susta
  • , K.A.J. Mitchelson
  • , E.D. Castro
  • , J.M.G. Senden
  • , J.P.B. Goessens
  • , A. Miklosz
  • , A. Chabowski
  • , R. Segurado
  • , C.A. Corish
  • , S.N. McCarthy
  • , B. Egan
  • , L.J.C. van Loon
  • , H.M. Roche*
  • *Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Background: Leucine-enriched protein (LEU-PRO) and long-chain (LC) n-3 (omega-3) PUFAs have each been proposed to improve muscle mass and function in older adults, whereas their combination may be more effective than either alone.

Objective: The impact of LEU-PRO supplementation alone and combined with LC n-3 PUFAs on appendicular lean mass, strength, physical performance and myofibrillar protein synthesis (MyoPS) was investigated in older adults at risk of sarcopenia.

Methods: This 24-wk, 3-arm parallel, randomized, double-blind, placebo-controlled trial was conducted in 107 men and women aged >= 65 y with low muscle mass and/or strength. Twice daily, participants consumed a supplement containing either LEU-PRO (3 g leucine, 10 g protein; n = 38), LEU-PRO plus LC n-3 PUFAs (0.8 g EPA, 1.1 g DHA; LEU-PRO+n-3; n = 38), or an isoenergetic control (CON; n = 31). Appendicular lean mass, handgrip strength, leg strength, physical performance, and circulating metabolic and renal function markers were measured pre, mid-, and postintervention. Integrated rates of MyoPS were assessed in a subcohort (n = 28).

Results: Neither LEU-PRO nor LEU-PRO+n-3 supplementation affected appendicular lean mass, handgrip strength, knee extension strength, physical performance or MyoPS. However, isometric knee flexion peak torque (treatment effect: -7.1 Nm; 95% CI: -12.5, -1.8 Nm; P < 0.01) was lower postsupplementation in LEU-PRO+n-3 compared with CON. Serum triacylglycerol and total adiponectin concentrations were lower, and HOMA-IR was higher, in LEU-PRO+n-3 compared with CON postsupplementation (all P < 0.05). Estimated glomerular filtration rate was higher and cystatin c was lower in LEU-PRO and LEU-PRO+n-3 postsupplementation compared with CON (all P < 0.05).

Conclusions: Contrary to our hypothesis, we did not observe a beneficial effect of LEU-PRO supplementation alone or combined with LC n-3 PUFA supplementation on appendicular lean mass, strength, physical performance or MyoPS in older adults at risk of sarcopenia.

Original languageEnglish
Pages (from-to)1411-1427
Number of pages17
JournalAmerican Journal of Clinical Nutrition
Volume113
Issue number6
DOIs
Publication statusPublished - 1 Jun 2021

Keywords

  • aging
  • LC n-3 PUFA
  • leucine
  • protein
  • muscle mass
  • strength
  • sarcopenia
  • AMINO-ACID SUPPLEMENTATION
  • DIETARY-FAT MODIFICATION
  • SERUM CYSTATIN-C
  • HEALTHY OLDER
  • BODY-COMPOSITION
  • VITAMIN-D
  • RISK-FACTORS
  • ELDERLY-PEOPLE
  • EXERCISE
  • AGE

Fingerprint

Dive into the research topics of 'Does supplementation with leucine-enriched protein alone and in combination with fish-oil-derived n-3 PUFA affect muscle mass, strength, physical performance, and muscle protein synthesis in well-nourished older adults? A randomized, double-blind, placebo-controlled trial'. Together they form a unique fingerprint.

Cite this